Mark and Glenn Turchan are early investors in Refana, a company on the leading-edge of vaccine technology

Read their story

'No one is safe until everyone is safe'

​Tedros Adhanom Ghebreyesus
​WHO Director General

corporate relations

For further information please contact:

mark turchan

Corporate Relations Americas
​mpturchan@gmail.com

gerard lawless

Corporate Relations EMEA
gerardlawless@foxbridgecapital.com

tom barry

Corporate Relations EMEA
tom.barry@capriam.com